SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ambalal Sarabhai Ent reports Profit after tax of Rs 11.16 Mln, in the March 2023 quarter

30 May 2023 Evaluate
The total revenue hovered 191.34% to Rs. 3.70 millions for the March 2023 quarter as against Rs. 1.27 millions during the corresponding quarter last year.The Total Profit for the quarter ended March 2023 of Rs. 11.16 millions grew from Rs.-104.18 millionsOperating Profit reported a sharp decline to 20.48 millions from 52.51 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 3.70 1.27 191.34 37.07 1.27 2818.90 37.07 1.27 2818.90
Other Income 33.46 67.70 -50.58 105.34 395.35 -73.36 105.34 395.35 -73.36
PBIDT 20.48 52.51 -61.00 53.76 339.68 -84.17 53.76 339.68 -84.17
Interest 0.48 1.26 -61.90 1.07 2.47 -56.68 1.07 2.47 -56.68
PBDT 12.55 -98.39 -112.76 44.81 36.44 22.97 44.81 36.44 22.97
Depreciation 0.26 0.48 -45.83 1.45 1.92 -24.48 1.45 1.92 -24.48
PBT 12.29 -98.87 -112.43 43.36 34.52 25.61 43.36 34.52 25.61
TAX 1.13 5.31 -78.72 2.26 4.96 -54.44 2.26 4.96 -54.44
Deferred Tax 1.13 7.81 -85.53 2.26 7.46 -69.71 2.26 7.46 -69.71
PAT 11.16 -104.18 -110.71 41.10 29.56 39.04 41.10 29.56 39.04
Equity 766.33 766.33 0.00 766.33 766.33 0.00 766.33 766.33 0.00
PBIDTM(%) 553.51 4134.65 -86.61 145.02 26746.46 -99.46 145.02 26746.46 -99.46

Ambalal Sarabhai Ent Share Price

31.07 -0.26 (-0.83%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1850.40
Dr. Reddys Lab 1310.50
Cipla 1365.25
Zydus Lifesciences 939.10
Lupin 2442.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×